$GLRE earnings report

GREENLIGHT RE ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2026 Delivers Strong Underwriting Result with 90.5% Combined Ratio; Repurchases $8.0 million of ordinary shares during the quarter. AlphAI read Greenlight Capital Re's Third quarter and nine months ended September 30, 2026 filing as mixed.

Third quarter and nine months ended September 30, 2026

AlphAI · Earnings readGLRE · Third quarter and nine months ended September 30, 2026 · ended September 30, 2026

GREENLIGHT RE ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2026 Delivers Strong Underwriting Result with 90.5% Combined Ratio; Repurchases $8.0 million of ordinary shares during the quarter

→Mixed quarter

Third-quarter underwriting remained profitable with a 90.5% combined ratio and net income of $3.2 million, but net premiums earned and net underwriting income declined, the combined ratio deteriorated, and Solasglas returned -3.3%.

Open Market, three months ended September 30, 2026 net premiums earned
$125M
EPS · non-GAAP
$ 20.78
0.8 % q/q

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Three months ended September 30, 2026 gross premiums writtenGAAP$181.9M–decreased 1%
Three months ended September 30, 2026 gross premiums cededGAAP−$39.17M––
Three months ended September 30, 2026 net premiums writtenGAAP$142.7M––
Three months ended September 30, 2026 net premiums earnedGAAP$153.4M–decreased 7%
Three months ended September 30, 2026 current year net loss and LAE incurredGAAP−$81.88M––
Three months ended September 30, 2026 prior year net loss and LAE incurredGAAP−$2.49M––
Three months ended September 30, 2026 net loss and LAE incurredGAAP−$84.36M––
Three months ended September 30, 2026 acquisition costsGAAP−$45.52M––
Three months ended September 30, 2026 underwriting expensesGAAP−$8.91M––
Three months ended September 30, 2026 deposit interest expenseGAAP$ (31)––
Three months ended September 30, 2026 net underwriting incomeGAAP$14.60M––
Three months ended September 30, 2026 loss from investment in SolasglasGAAP−$15.13M––
Three months ended September 30, 2026 net investment income (loss)GAAP$10.49M––
Three months ended September 30, 2026 total investment income (loss)GAAP−$4.64M––
Three months ended September 30, 2026 corporate and other expensesGAAP−$5.72M––
Three months ended September 30, 2026 foreign exchange gains (losses)GAAP$ (495)––
Three months ended September 30, 2026 interest expenseGAAP$ (127)––
Three months ended September 30, 2026 income tax expenseGAAP$ (389)––
Three months ended September 30, 2026 net income (loss)GAAP$3.23M––
Three months ended September 30, 2026 basic earnings per shareGAAP$ 0.10––
Three months ended September 30, 2026 diluted earnings per shareGAAP$ 0.10––
Three months ended September 30, 2026 current year loss ratioother53.4 %––
Three months ended September 30, 2026 prior year reserve development ratioother1.6 %––
Three months ended September 30, 2026 loss ratioother55.0 %––
Three months ended September 30, 2026 acquisition cost ratioother29.7 %––
Three months ended September 30, 2026 composite ratioother84.7 %––
Three months ended September 30, 2026 underwriting expense ratioother5.8 %––
Three months ended September 30, 2026 combined ratioother90.5 %––
Nine months ended September 30, 2026 gross premiums writtenGAAP$592.9M–decreased 3%
Nine months ended September 30, 2026 net premiums earnedGAAP$469.4M–decreased 5%
Nine months ended September 30, 2026 net underwriting incomeGAAP$20.56M––
Nine months ended September 30, 2026 total investment incomeGAAP$12.00M––
Nine months ended September 30, 2026 net incomeGAAP$9.39M––
Nine months ended September 30, 2026 basic earnings per shareGAAP$ 0.28––
Nine months ended September 30, 2026 diluted earnings per shareGAAP$ 0.28––
Nine months ended September 30, 2026 combined ratioother95.6 %––
September 30, 2026 fully diluted book value per sharenon-GAAP$ 20.780.8 %–

Segments

SegmentRevenueq/qy/y
Open Market, three months ended September 30, 2026 net premiums earnedNo segment-specific driver was disclosed.$125.3M––
Innovations, three months ended September 30, 2026 net premiums earnedNo segment-specific driver was disclosed.$28.12M––
Open Market, nine months ended September 30, 2026 net premiums earnedNo segment-specific driver was disclosed.$391.2M––
Innovations, nine months ended September 30, 2026 net premiums earnedNo segment-specific driver was disclosed.$78.16M––

Capital returns

  • Repurchased $8.0 million of ordinary shares at an average cost of $15.77 per share during the third quarter.
  • Repurchased $27.2 million of ordinary shares at an average cost of $16.90 per share for the nine months ended September 30, 2026.
  • From October 1, 2026, to October 30, 2026, the Company repurchased an additional $3.3 million of ordinary shares at an average price of $14.95 per share.

What drove it

  • Third-quarter underwriting income was aided by a relatively benign catastrophe and large loss environment.
  • The conservative reserving approach on Middle East-related exposures taken in the prior quarter developed favorably.
  • Gains on the Innovations portfolio and buybacks contributed to the increase in fully diluted book value per share.
  • The investment portfolio was challenging and Solasglas returned -3.3% in the third quarter.

Concerns

  • Third-quarter net premiums earned decreased 7% to $153.4 million.
  • Third-quarter net underwriting income was $14.6 million, compared to $22.3 million.
  • The third-quarter combined ratio was 90.5%, compared to 86.6%.
  • Solasglas returned -3.3% during the third quarter.
  • Nine-month net income was $9.4 million, compared to $25.6 million, and nine-month combined ratio was 95.6%, compared to 95.4%.

What to watch

  • Development of Middle East-related exposures and the catastrophe and large loss environment.
  • Underwriting profitability, including the combined ratio and underwriting expense ratio.
  • Solasglas investment performance and the contribution from the Innovations portfolio.
  • Further ordinary-share repurchases following the $3.3 million repurchased from October 1, 2026, to October 30, 2026.

Balance sheet and cash flow

  • Cash and cash equivalents were $ 70,982 at September 30, 2026, compared to $ 111,756 at December 31, 2025.
  • Restricted cash and cash equivalents were $ 511,983 at September 30, 2026, compared to $ 531,976 at December 31, 2025.
  • Total investments were $ 731,742 at September 30, 2026, compared to $ 633,075 at December 31, 2025.
  • Reinsurance balances receivable were $ 683,363 at September 30, 2026, compared to $ 664,381 at December 31, 2025.
  • Loss and loss adjustment expense reserves were $ 1,024,891 at September 30, 2026, compared to $ 967,960 at December 31, 2025.
  • Unearned premium reserves were $ 401,152 at September 30, 2026, compared to $ 361,704 at December 31, 2025.
  • Debt was $ 4,768 at September 30, 2026, compared to $ 4,724 at December 31, 2025.
  • Total shareholders' equity was $ 694,547 at September 30, 2026, compared to $ 707,977 at December 31, 2025.
  • Total assets were $ 2,290,574 at September 30, 2026, compared to $ 2,169,783 at December 31, 2025.
  • Operating cash flow and free cash flow were not reported.

Analysis

Greenlight Re reported third-quarter net income of $3.2 million, or $0.10 per diluted ordinary share, after a net loss of $4.4 million, or $(0.13) per diluted ordinary share, in the prior-year quarter. The improvement occurred despite a total investment loss of $4.6 million. That loss was narrower than the $17.4 million loss reported a year earlier, while underwriting remained profitable at $14.6 million.

Premium volume declined in the quarter. Gross premiums written decreased 1% to $181.9 million and net premiums earned decreased 7% to $153.4 million. Net underwriting income fell from $22.3 million, and the combined ratio increased to 90.5% from 86.6%. The loss ratio rose to 55.0% from 53.6%, while the acquisition cost ratio rose to 29.7% from 28.1% and the underwriting expense ratio rose to 5.8% from 4.9%.

Management attributed the quarter's underwriting result to a relatively benign catastrophe and large loss environment, along with favorable development on Middle East-related exposures. Segment disclosures show Open Market produced $15,193 of underwriting income and Innovations produced $494, while the Corporate segment had an underwriting loss of $1,085. Open Market's combined ratio was 87.9%, versus 98.2% for Innovations.

Investment results remained a limiting factor. Solasglas generated a loss of $15,133 in the quarter and management said it returned -3.3%, although net investment income was $10,493 and total investment loss improved materially from the prior-year loss. For the nine months, total investment income was $12.0 million compared with $15.3 million, while net income was $9.4 million compared with $25.6 million. The nine-month combined ratio was 95.6%, compared with 95.4%.

The company continued to return capital through repurchases, buying $8.0 million of ordinary shares in the quarter and $27.2 million in the first nine months, followed by an additional $3.3 million through October 30. Fully diluted book value per share increased 0.8% to $20.78 from $20.61 at June 30, 2026, aided by underwriting, Innovations gains and buybacks. Total shareholders' equity was $694,547 at September 30, 2026, compared with $707,977 at December 31, 2025. No forward financial guidance was provided.

Management, verbatim

We are pleased to report strong underwriting income in the third quarter, aided by a relatively benign catastrophe and large loss environment. The conservative reserving approach we took on Middle East–related exposures last quarter has developed favorably, and our year-to-date underwriting result is now trending in line with our expectations.

Greg Richardson, Chief Executive Officer of Greenlight Re

The third quarter continued to be challenging for our investment portfolio and Solasglas returned -3.3%. However, our good underwriting result, coupled by gains on our Innovations portfolio and buybacks, contributed to an increase in fully diluted book value per share.

David Einhorn, Chairman of the Board of Directors

Not in the filing

stated, not guessed
  • Forward revenue, gross margin, operating expense, tax-rate, and other financial guidance were not provided.
  • Prior-outlook guidance was not provided.
  • Operating cash flow was not reported.
  • Free cash flow was not reported.
  • A conventional revenue line was not reported; the filing reports gross premiums written, net premiums written, and net premiums earned.
  • Non-GAAP earnings, non-GAAP operating income, and non-GAAP EPS were not reported.
  • Segment-level year-over-year and sequential percentage changes were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about GLRE earnings dates

When is Greenlight Capital Re's next earnings date?
AlphAI has no date for GLRE yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.